Orthocell files EU–UK regulatory bid for Remplir™, targeting US$750m nerve repair market

Orthocell Ltd (ASX:OCC, OTC:ORHHF) has moved to unlock access to the EU and UK’s US$750 million nerve repair market, submitting its regulatory application...